Immunomodulatory therapies in neurologic critical care (Q37602031)

21 August 2017

1 reference

title

Immunomodulatory therapies in neurologic critical care (English)

1 reference

21 August 2017

Logan M McDaneld

1

1 reference

21 August 2017

Jeremy D Fields

series ordinal

2

1 reference

21 August 2017

Dennis N Bourdette

series ordinal

3

1 reference

21 August 2017

Anish Bhardwaj

series ordinal

4

1 reference

21 August 2017

23 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

12

1 reference

21 August 2017

1

1 reference

21 August 2017

132-143

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-009-9274-0

21 August 2017

0 references

cites work

Practice parameter: Immunotherapy for Guillain-Barre syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Treatment of autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Isolated angiitis of the CNS in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Diagnosis and management of isolated angiitis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers--report of 5 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Steroids in intractable childhood epilepsy: clinical experience and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Prednisone therapy in pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9274-0

Hashimoto encephalopathy: syndrome or myth?

21 January 2018

1 reference

12 December 2020

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

12 December 2020

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

1 reference

12 December 2020

Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels.

1 reference

12 December 2020

Intravenous immunoglobulin for multifocal motor neuropathy

1 reference

12 December 2020

Intravenous immunoglobulin: adverse effects and safe administration

1 reference

12 December 2020

Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies

1 reference

12 December 2020

Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa

1 reference

12 December 2020

Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination

1 reference

12 December 2020

Mitoxantrone for multiple sclerosis

1 reference

12 December 2020

Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange

1 reference

12 December 2020

Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer

1 reference

12 December 2020

Voltage‐gated potassium channel antibodies in limbic encephalitis

1 reference

12 December 2020

An Update on Myasthenic Crisis.

1 reference

12 December 2020

Autonomic involvement in Guillain-Barré syndrome: a review

1 reference

12 December 2020

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis

1 reference

12 December 2020

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.

1 reference

12 December 2020

Primary central nervous system vasculitis: progress and questions

1 reference

12 December 2020

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

1 reference

12 December 2020

Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome

1 reference

12 December 2020

Focal cortical resection for complex partial status epilepticus due to a paraneoplastic encephalitis.

1 reference

12 December 2020

Plasmapheresis-related hypotension

1 reference

12 December 2020

Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience

1 reference

12 December 2020

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

1 reference

12 December 2020

Acute fulminant multiple sclerosis and plasma exchange

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.

1 reference

12 December 2020

Hashimot's encephalopathy-response to intravenous immunoglobulin.

1 reference

12 December 2020

Plasmapheresis in fulminant acute disseminated encephalomyelitis

1 reference

12 December 2020

Use of therapeutic plasma exchange in the management of acute hemorrhagic leukoencephalitis: a case report and review of the literature.

1 reference

12 December 2020

What's in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis?

1 reference

12 December 2020

Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

1 reference

12 December 2020

Axonal Guillain-Barré syndrome: a critical review

1 reference

12 December 2020

Primary central nervous system vasculitis in children

1 reference

12 December 2020

Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg

1 reference

12 December 2020

Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients

1 reference

12 December 2020

1 reference

12 December 2020

Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

1 reference

12 December 2020

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

12 December 2020

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

1 reference

12 December 2020

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

1 reference

12 December 2020

Immunoadsorption therapy for myasthenia gravis

1 reference

12 December 2020

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS

1 reference

12 December 2020

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

1 reference

12 December 2020

A short plasma exchange protocol is effective in severe myasthenia gravis

1 reference

12 December 2020

Serum antibodies in epilepsy and seizure-associated disorders

1 reference

12 December 2020

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

12 December 2020

Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

12 December 2020

Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis

1 reference

12 December 2020

Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician

1 reference

12 December 2020

Vasculitis of the nervous system

1 reference

12 December 2020

Nonvasculitic autoimmune inflammatory meningoencephalitis

1 reference

12 December 2020

Cyclophosphamide treatment of primary angiitis of the central nervous system in children: report of 2 cases.

1 reference

12 December 2020

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

12 December 2020

ACTH therapy for generalized seizures other than spasms

1 reference

12 December 2020

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study

1 reference

12 December 2020

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

12 December 2020

Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment

1 reference

12 December 2020

Glucocorticoid therapy in neurologic critical care

1 reference

12 December 2020

Venous and arterial thrombosis following administration of intravenous immunoglobulins

1 reference

12 December 2020

Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy

1 reference

12 December 2020

Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis.

1 reference

12 December 2020

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

12 December 2020

Immunomodulatory treatment trial for paraneoplastic neurological disorders

1 reference

12 December 2020

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

1 reference

12 December 2020

Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data

1 reference

12 December 2020

Primary central nervous system vasculitis: analysis of 101 patients

1 reference

12 December 2020

High-dose, rapid-infusion IVIG in postvaccination acute disseminated encephalomyelitis

1 reference

12 December 2020

Therapeutic plasma exchange: complications and management

1 reference

12 December 2020

Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins

1 reference

12 December 2020

Long-term beneficial effects of dexamethasone on intellectual and neuropsychological outcome of children with pneumococcal meningitis

1 reference

12 December 2020

Lifetime course of myasthenia gravis

1 reference

12 December 2020

Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins

1 reference

12 December 2020

Therapy of myasthenic crisis

1 reference

12 December 2020

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

1 reference

12 December 2020

Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids

1 reference

12 December 2020

Acute disseminated encephalomyelitis

1 reference

12 December 2020

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

1 reference

12 December 2020

Intravenous immunoglobulin for Guillain-Barré syndrome

1 reference

12 December 2020

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

1 reference

12 December 2020

Autoimmune encephalopathies

1 reference

12 December 2020

Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy

1 reference

12 December 2020

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis.

1 reference

12 December 2020

Plasmapheresis in Rasmussen's encephalitis

1 reference

12 December 2020

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

1 reference

12 December 2020

Intensive Plasma Exchange on the Cell Separator: Effects on Serum Immunoglobulins and Complement Components

1 reference

12 December 2020

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

12 December 2020

Acute disseminated encephalomyelitis: response to intravenous immunoglobulin

1 reference

12 December 2020

Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome

1 reference

12 December 2020

Acetylcholine receptors and myasthenia

1 reference

12 December 2020

Immunosuppressive treatment for non-systemic vasculitic neuropathy

1 reference

12 December 2020

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

1 reference

12 December 2020

Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis.

1 reference

12 December 2020

Hashimoto's encephalopathy : epidemiology, pathogenesis and management

1 reference

12 December 2020

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

1 reference

12 December 2020

Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis

1 reference

12 December 2020

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

12 December 2020

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

1 reference

12 December 2020

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

12 December 2020

Hashimoto's encephalopathy responding to plasmapheresis.

1 reference

12 December 2020

High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus

1 reference

12 December 2020

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.

1 reference

12 December 2020

Practice guidelines for the management of bacterial meningitis

1 reference

12 December 2020

Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis

1 reference

12 December 2020

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

12 December 2020

Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study

1 reference

12 December 2020

Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study

1 reference

12 December 2020

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

1 reference

12 December 2020

Plasmapheresis in myasthenia gravis. A comparative study of daily versus alternately daily schedule

1 reference

12 December 2020

Treatment for IgG and IgA paraproteinaemic neuropathy

1 reference

12 December 2020

Potassium channel antibodies in two patients with reversible limbic encephalitis

1 reference

12 December 2020

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

12 December 2020

Hashimoto's encephalopathy: response to plasma exchange.

1 reference

12 December 2020

Hashimoto's encephalopathy.

1 reference

12 December 2020

Corticosteroids for myasthenia gravis

1 reference

12 December 2020

Intravenous immunoglobulin in the treatment of acute disseminated encephalomyelitis.

1 reference

12 December 2020

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis

1 reference

12 December 2020

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

1 reference

12 December 2020

Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy

1 reference

12 December 2020

Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis

1 reference

12 December 2020

Therapeutic apheresis in neurological disorders

1 reference

12 December 2020

Epilepsy: an autoimmune disease?

1 reference

12 December 2020

Myasthenic crisis: guidelines for prevention and treatment

1 reference

12 December 2020

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial

1 reference

12 December 2020

Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: when and how to treat?

1 reference

12 December 2020

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

12 December 2020

Paraneoplastic Syndromes Involving the Nervous System

1 reference

12 December 2020

Peripheral neuropathies and anti-glycolipid antibodies

1 reference

12 December 2020

Safety of IGIV therapy and infusion-related adverse events

1 reference

12 December 2020

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

12 December 2020

Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis

1 reference

12 December 2020

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

12 December 2020

Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor

1 reference

12 December 2020

Acute disseminated encephalomyelitis treated with plasmapheresis.

1 reference

12 December 2020

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin

1 reference

12 December 2020

Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination

1 reference

12 December 2020

Neurology of the vasculitides and connective tissue diseases

1 reference

12 December 2020

Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates

1 reference

12 December 2020

Steroid-responsive encephalopathy associated with autoimmune thyroiditis

1 reference

12 December 2020

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

12 December 2020

Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment

1 reference

12 December 2020

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

12 December 2020

The antiinflammatory IgG.

1 reference

12 December 2020

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

1 reference

12 December 2020

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

1 reference

12 December 2020

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

12 December 2020

Central nervous system vasculitis in the intensive care unit.

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Plasma exchange for Guillain-Barré syndrome.

1 reference

12 December 2020

Primary angiitis of the central nervous system: report of five biopsy-confirmed cases from Colombia

1 reference

12 December 2020

10.1007/S12028-009-9274-0

Identifiers

DOI

1 reference

21 August 2017

1 reference